Cargando…

Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice

Autoantigen-specific immunological tolerance represents a central objective for prevention of type 1 diabetes (T1D). Previous studies demonstrated mucosal antigen administration results in expansion of Foxp3(+) and LAP(+) regulatory T cells (Tregs), suggesting oral delivery of self-antigens might re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Posgai, Amanda L., Wasserfall, Clive H., Kwon, Kwang-Chul, Daniell, Henry, Schatz, Desmond A., Atkinson, Mark A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304332/ https://www.ncbi.nlm.nih.gov/pubmed/28205558 http://dx.doi.org/10.1038/srep42372

Ejemplares similares

Oral Delivery of Protein Drugs Bioencapsulated in Plant Cells
por: Kwon, Kwang-Chul, et al.
Publicado: (2016)

Acute Versus Progressive Onset of Diabetes in NOD Mice: Potential Implications for Therapeutic Interventions in Type 1 Diabetes
por: Mathews, Clayton E., et al.
Publicado: (2015)

Combination Therapy Reverses Hyperglycemia in NOD Mice With Established Type 1 Diabetes
por: Xue, Song, et al.
Publicado: (2015)

Oral delivery of bi-autoantigens by bacterium-like particles (BLPs) against autoimmune diabetes in NOD mice
por: Mao, Ruifeng, et al.
Publicado: (2023)

Immune Depletion in Combination with Allogeneic Islets Permanently Restores Tolerance to Self-Antigens in Diabetic NOD Mice
por: Gagliani, Nicola, et al.
Publicado: (2015)

Plant cell-made protein antigens for induction of Oral tolerance
por: Daniell, Henry, et al.
Publicado: (2019)

Progressive Erosion of β-Cell Function Precedes the Onset of Hyperglycemia in the NOD Mouse Model of Type 1 Diabetes
por: Ize-Ludlow, Diego, et al.
Publicado: (2011)

Transient B-Cell Depletion with Anti-CD20 in Combination with Proinsulin DNA Vaccine or Oral Insulin: Immunologic Effects and Efficacy in NOD Mice
por: Sarikonda, Ghanashyam, et al.
Publicado: (2013)

Vitamin D Levels in Subjects With and Without Type 1 Diabetes Residing in a Solar Rich Environment
por: Bierschenk, Lindsey, et al.
Publicado: (2009)

Exocrine and Endocrine Inflammation Increases Cellular Replication in the Pancreatic Duct Compartment in Type 1 Diabetes
por: Kulkarni, Shweta, et al.
Publicado: (2022)

Combination Therapy With Glucagon-Like Peptide-1 and Gastrin Restores Normoglycemia in Diabetic NOD Mice
por: Suarez-Pinzon, Wilma L., et al.
Publicado: (2008)

Role of Small Intestine and Gut Microbiome in Plant-Based Oral Tolerance for Hemophilia
por: Kumar, Sandeep R. P., et al.
Publicado: (2020)

Serum Trypsinogen Levels in Type 1 Diabetes
por: Li, Xia, et al.
Publicado: (2017)

Influence of Membrane CD25 Stability on T Lymphocyte Activity: Implications for Immunoregulation
por: Brusko, Todd M., et al.
Publicado: (2009)

Affordable oral health care: dental biofilm disruption using chloroplast made enzymes with chewing gum delivery
por: Singh, Rahul, et al.
Publicado: (2021)

Interleukin-10(+) Regulatory B Cells Arise Within Antigen-Experienced CD40(+) B Cells to Maintain Tolerance to Islet Autoantigens
por: Kleffel, Sonja, et al.
Publicado: (2015)

Plant‐based oral vaccines against zoonotic and non‐zoonotic diseases
por: Shahid, Naila, et al.
Publicado: (2016)

Increased Complement Activation in Human Type 1 Diabetes Pancreata
por: Rowe, Patrick, et al.
Publicado: (2013)

Expression and assembly of largest foreign protein in chloroplasts: oral delivery of human FVIII made in lettuce chloroplasts robustly suppresses inhibitor formation in haemophilia A mice
por: Kwon, Kwang‐Chul, et al.
Publicado: (2017)

Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes
por: Campbell-Thompson, Martha, et al.
Publicado: (2016)

Death, autoantigen modifications, and tolerance
por: Utz,, Paul J, et al.
Publicado: (2000)

Application of a Genetic Risk Score to Racially Diverse Type 1 Diabetes Populations Demonstrates the Need for Diversity in Risk-Modeling
por: Perry, Daniel J., et al.
Publicado: (2018)

A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice
por: Gill, Ronald G., et al.
Publicado: (2016)

Immunomodulatory Dual-Sized Microparticle System Conditions Human Antigen Presenting Cells Into a Tolerogenic Phenotype In Vitro and Inhibits Type 1 Diabetes-Specific Autoreactive T Cell Responses
por: Brusko, Maigan A., et al.
Publicado: (2020)

Copolymeric Micelles Overcome the Oral Delivery Challenges of Amphotericin B
por: Nimtrakul, Pataranapa, et al.
Publicado: (2020)

The Tyrphostin Agent AG490 Prevents and Reverses Type 1 Diabetes in NOD Mice
por: Davoodi-Semiromi, Abdoreza, et al.
Publicado: (2012)

Genetic Composition and Autoantibody Titers Model the Probability of Detecting C-Peptide Following Type 1 Diabetes Diagnosis
por: Williams, MacKenzie D., et al.
Publicado: (2021)

Comparative Pathogenesis of Autoimmune Diabetes in Humans, NOD Mice, and Canines: Has a Valuable Animal Model of Type 1 Diabetes Been Overlooked?
por: O’Kell, Allison L., et al.
Publicado: (2017)

339 A serum exocrine enzyme as a biomarker of response to immunotherapy in type 1 diabetes.
por: Bruggeman, Brittany S, et al.
Publicado: (2022)

How Do We Move Type 1 Diabetes Immunotherapies Forward During the Current COVID-19 Pandemic?
por: Haller, Michael J., et al.
Publicado: (2021)

Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes
por: Haller, Michael J., et al.
Publicado: (2016)

Inhibition of VEGFR-2 Reverses Type 1 Diabetes in NOD Mice by Abrogating Insulitis and Restoring Islet Function
por: Villalta, S. Armando, et al.
Publicado: (2013)

Taking a Daily Vitamin to Prevent Type 1 Diabetes?
por: Wasserfall, Clive, et al.
Publicado: (2009)

Influence of Fecal Sample Storage on Bacterial Community Diversity
por: Roesch, Luiz F. W, et al.
Publicado: (2009)

PTMA, a new identified autoantigen for oral submucous fibrosis, regulates oral submucous fibroblast proliferation and extracellular matrix
por: Wang, Jie, et al.
Publicado: (2017)

Preclinical development of plant‐based oral immune modulatory therapy for haemophilia B
por: Srinivasan, Aparajitha, et al.
Publicado: (2021)

Oral Tolerance Induction in Hemophilia B Dogs Fed with Transplastomic Lettuce
por: Herzog, Roland W., et al.
Publicado: (2017)

Autoantigen-Specific B-Cell Depletion Overcomes Failed Immune Tolerance in Type 1 Diabetes
por: Henry, Rachel A., et al.
Publicado: (2012)

Impaired tolerance to the autoantigen LL-37 in acute coronary syndrome
por: Chernomordik, Fernando, et al.
Publicado: (2023)

A Novel Tolerogenic Antibody Targeting Disulfide-Modified Autoantigen Effectively Prevents Type 1 Diabetes in NOD Mice
por: Li, Wei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rlh8q5ka6bk4scgncacclhrinb